"Not to take anything away from your second point, or anyone else's frustration statements with management abilities we all have to admit one thing, we are still alive. Most biotechs that have failed, or should I say not passed a number of trials with their drug candidate would have folded up and closed their doors long ago. DM as good or bad as anyone thinks has kept this thing going for 22 or 23 years now. Not saying that's good or bad, just a fact."

Well said tada. I guess having ~70% of insiders owing the RVX stock paid off thus far. They don't want to see it fail.

Koo